Skip to main content

Table 2 Characteristics of patients who developed mild asymptomatic hypercalcemia after vitamin D supplementation

From: High-dose versus low-dose ergocalciferol for correcting hypovitaminosis D after fragility hip fracture: a randomized controlled trial

Patient no. Group allocation Baseline laboratory value 12-week follow-up laboratory value
Serum 25(OH)D (ng/mL) eGFR (mL/min/1.73 m2) Corrected serum calcium (mg/dL) Serum phosphorus (mg/dL) Serum 25(OH)D (ng/mL) eGFR (mL/min/1.73 m2) Corrected serum calcium (mg/dL) Serum phosphorus (mg/dL)
1 Low-dose 20.7 84.6 9.8 3.1 29.4 82.2 10.5 3.4
2 High-dose 17.4 42.6 10.1 3.5 45.0 43.3 11.1 3.7
3 High-dose 8.1 85.4 10.0 2.9 34.2 82.7 10.8 3.3